Early use of hemoadsorption in patients after out-of hospital cardiac arrest - a matched pair analysis.

Muharrem AkinVera GarchevaJan-Thorben SiewekeUlrike FlierlHannah C DaumJohann BauersachsAndreas Schäfer

Published in: PloS one (2020)

Routine use of hemoadsorption did not reduce, but seems to be associated with higher 30-day mortality in patients after OHCA. Prior to routine adoption in daily practice, hemoadsorption should be evaluated in properly sized randomized controlled trials.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
randomized controlled trial
prognostic factors
healthcare
primary care
clinical practice
type diabetes
patient reported outcomes
cardiovascular events
quality improvement
patient reported